Innospec Inc. (IOSP - Free Report) has launched a new technology, which is geared to improve the operation of direct injection gasoline engines.
Gasoline Direct Injection (“GDI”) engines have improved fuel economy and higher output compared with traditional engines. In addition, the engines offer the opportunity to utilize smaller and lighter power units. This highly effective technology is on the verge of becoming the new engine of choice for premium gasoline vehicles.
Per Innospec, its products will help to reduce emissions from engines and improve fuel economy. Moreover, the global infrastructure of the company supports customers all over the world, as they roll-out this new improved technology.
Shares of Innospec have lost 1.5% over a year compared to the industry’s 20.8% decline.
The chemical maker’s revenues increased on a year-over-year basis in the third quarter, driven by sales gains in core businesses.
During third-quarter earnings call, Innospec said that it will remain focused on key actions to further boost cash generation in the final quarter of 2018. The company is also engaged in acquisition opportunities, which it believes will strengthen business.
Revenues across the company’s Fuel Specialties, Performance Chemicals and Oilfield Services segments increased year over year in the third quarter on the back of higher volumes and favorable price/mix impact. However, Octane Additives division’s revenues declined on a year-over-year basis.
Innospec Inc. Price and Consensus
Zacks Rank & Other Stocks to Consider
Innospec currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the basic materials space include CF Industries Holdings, Inc. (CF - Free Report) , The Mosaic Company (MOS - Free Report) and Methanex Corporation (MEOH - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
CF Industries has an expected long-term earnings growth rate of 6%. The company’s shares have gained 20% in the past year.
Mosaic has an expected long-term earnings growth rate of 7%. The stock has rallied 45.2% over the past year.
Methanex has an expected long-term earnings growth rate of 15%. Its shares have gained 7% in the past year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Innospec Inc. (IOSP - Free Report) has launched a new technology, which is geared to improve the operation of direct injection gasoline engines.
Gasoline Direct Injection (“GDI”) engines have improved fuel economy and higher output compared with traditional engines. In addition, the engines offer the opportunity to utilize smaller and lighter power units. This highly effective technology is on the verge of becoming the new engine of choice for premium gasoline vehicles.
Per Innospec, its products will help to reduce emissions from engines and improve fuel economy. Moreover, the global infrastructure of the company supports customers all over the world, as they roll-out this new improved technology.
Shares of Innospec have lost 1.5% over a year compared to the industry’s 20.8% decline.
The chemical maker’s revenues increased on a year-over-year basis in the third quarter, driven by sales gains in core businesses.
During third-quarter earnings call, Innospec said that it will remain focused on key actions to further boost cash generation in the final quarter of 2018. The company is also engaged in acquisition opportunities, which it believes will strengthen business.
Revenues across the company’s Fuel Specialties, Performance Chemicals and Oilfield Services segments increased year over year in the third quarter on the back of higher volumes and favorable price/mix impact. However, Octane Additives division’s revenues declined on a year-over-year basis.
Innospec Inc. Price and Consensus
Zacks Rank & Other Stocks to Consider
Innospec currently carries a Zacks Rank #2 (Buy).
Other top-ranked stocks in the basic materials space include CF Industries Holdings, Inc. (CF - Free Report) , The Mosaic Company (MOS - Free Report) and Methanex Corporation (MEOH - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
CF Industries has an expected long-term earnings growth rate of 6%. The company’s shares have gained 20% in the past year.
Mosaic has an expected long-term earnings growth rate of 7%. The stock has rallied 45.2% over the past year.
Methanex has an expected long-term earnings growth rate of 15%. Its shares have gained 7% in the past year.
Looking for Stocks with Skyrocketing Upside?
Zacks has just released a Special Report on the booming investment opportunities of legal marijuana.
Ignited by new referendums and legislation, this industry is expected to blast from an already robust $6.7 billion to $20.2 billion in 2021. Early investors stand to make a killing, but you have to be ready to act and know just where to look.
See the pot trades we're targeting>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on CF - FREE
Get the latest research report on MEOH - FREE
Get the latest research report on MOS - FREE
Get the latest research report on IOSP - FREE